Hepatic Disease in Patients With HIV
Summary
- AASLD/IDSA and EASL guidance panels recommend highly active DAA regimens for genotype 1 HCV/HIV–coinfected patients (Management Guidelines)[AASLD-IDSA HCV] (Management Guidelines)[EASL HCV]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content